NCT02227030View on ClinicalTrials.gov

Tolerability and Pharmacokinetics of BIIB 722 CL Drinking Solution and of BIIB 722 CL Filmcoated Tablet in Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

71

Participants

Timeline

Start Date

April 30, 2000

Primary Completion Date

September 30, 2000

Conditions
Healthy
Interventions
DRUG

BIIB 722 CL solution

DRUG

BIIB 722 CL tablet

DRUG

Placebo solution

DRUG

Placebo tablet

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY